Sharekhan's research report on Lupin
Lupin Limited (Lupin) reported a weak Q1FY2023. OPM surprised negatively, marred by pricing pressures in the US and remediation cost at its plants. Yet, the management has shared a strong growth outlook across its US and India businesses. Further, given cost-control measures and few high-value launches lined up in the US, Lupin expects to end FY2023 with 18% OPM as compared to 6.2% in Q1FY2023.
Outlook
Based on the encouraging outlook, we retain our Buy recommendation on the stock with an unchanged price target (PT) of Rs. 780.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
